Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00765570 · ClinicalTrials.gov registry record · Phase 2
Study of Advanced Bulky Malignancies With Spatially Fractioned Radiation Therapy
A Phase 2 study, sponsored by Summa Health System.
- Terminated
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
NCT00765570: Clinical Trial Phase 2 study, sponsored by Summa Health System.
NCT00765570 is a Phase 2 study that was terminated before completion, run by Summa Health System. The registered enrollment target is 12 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00765570, a Phase 2 study, was terminated before completion, sponsored by Summa Health System.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
Study Summary
Expand clinical literature on the use of Grid radiation with conventional external beam therapy. Vast majority of therapy is for palliative care to provide relief from pain, but has also shown a reduction in the size of tumor mass.
Primary Outcome
Number of grade 3 or higher complications during the assesment period. This does not include any complication felt to be due solely to malignancy
Interventions
- RADIATION Spatially Fractioned Radiation Therapy
- RADIATION Treatment Group 1
- RADIATION Standard radiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2003-02 |
| Est. Completion | 2013-01 |
| Phase | Phase 2 |
Why NCT00765570 stopped before completion
NCT00765570 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 3 interventions - of which Spatially Fractioned Radiation Therapy is the first listed.
NCT00765570 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00765570 about?
NCT00765570 is a clinical study titled "Study of Advanced Bulky Malignancies With Spatially Fractioned Radiation Therapy". Expand clinical literature on the use of Grid radiation with conventional external beam therapy. Vast majority of therapy is for palliative care to provide relief from pain, but has also shown a reduction in the size of tumor mass.
What is the current status of trial NCT00765570?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2003-02. Estimated completion is 2013-01.
What interventions are being tested in trial NCT00765570?
The interventions under investigation include: Spatially Fractioned Radiation Therapy (RADIATION), Treatment Group 1 (RADIATION), Standard radiation (RADIATION).
Who is sponsoring clinical trial NCT00765570?
This trial is sponsored by Summa Health System, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00765570's enrollment target sits among peer trials
12 1948th of 2000 higher than 34 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia